Shearman & Sterling represented Francisco Partners in its planned acquisition of QuadraMed Corp in a deal valued at $126 million. The deal requires approval of QuadraMed shareholders. QuadraMed's directors, executive officers and affiliates, who control 8.4% of its common shares, have agreed to vote in favor of the deal.

QuadraMed Corp, based in Reston, VA, is a leading provider of healthcare technologies and services. Francisco Partners is one of the world’s largest technology-focused private equity funds, with approximately $5.0 billion of committed capital and offices in San Francisco and London.

The Shearman & Sterling team was led by San Francisco-based mergers & acquisitions partners Michael Dorf and Michael Kennedy and included partners Laurence Crouch (San Francisco-Tax), Tina Patel (Menlo Park-Intellectual Property) and Beau Buffier (New York-Antitrust), counsel Coleen O'Mara (San Francisco-Executive Compensation & Employee Benefits), and associates Jared Sams (San Francisco-M&A), Zheng Bao (Menlo Park-Intellectual Property), Hyun-Jeong Kim (New York-Executive Compensation & Employee Benefits), Kelly Karapetyan (New York-Antitrust) and Ajay Chanayil (New York-Antitrust).